Methods
All patients undergoing BS in Changi General Hospital (CGH) have their
data collected prospectively in the hospital database for audit
purposes. The patients who undergo BS are selected based on national
healthcare guidelines (BMI greater than 37.5 kg/m2 or
BMI greater than 32.5 kg/m2, with co-morbidities
related to obesity) and are treated by a multidisciplinary team
(comprising medical, nursing and allied health professionals) under a
standard pathway. The study was approved by the Institutional Review
Board (CIRB no: 2022/2195). Starting from January 2021 to December 2022,
from the database, we identified a group of five patients who have early
EC on fertility sparing treatment who also underwent BS for treatment of
morbid obesity. The patients who are on fertility sparing treatment for
EC are treated in a specialist gynecological oncology unit in KK Women’s
and Children’s Hospital (KKWCH) by a multidisciplinary team under a
standard pathway.
This is a retrospective case series. After consent was taken from
patients, we collected data from electronic medical records (EMR). The
data consisted of baseline patient characteristics, EC disease
characteristics, fertility sparing treatment details, BS details and
treatment outcome (in terms of EC regression, weight loss and
improvement in metabolic conditions) after BS. The descriptive analysis
of the data is show in the section below.